Biological evaluation of an antibiotic DC-81 - Indole conjugate agent in human melanoma cell lines

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 1, 2003, Pages 6-11

  Hu, Wan Ping ^a   Yu, Hsin Su ^a   Chen, Yen Chi ^a   Wang, Jeh Jeng ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DC 81; Indole carboxylate moiety; Melanoma; PBDs; Pyrrolo 2,1 c 1,4 benzodiazepines; XTT assay

Indexed keywords

1,2,3,11A TETRAHYDRO 8 HYDROXY 7 METHOXY 5H PYRROLO[2,1 C][1,4]BENZODIAZEPIN 5 ONE; ANTINEOPLASTIC ANTIBIOTIC; CARBOXYLIC ACID DERIVATIVE; INDOLE DERIVATIVE; NUCLEIC ACID SYNTHESIS INHIBITOR; PYRROLO[2,1 C][1,4]BENZODIAZEPINE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; CYTOPATHOGENIC EFFECT; DRUG CONJUGATION; DRUG DNA BINDING; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYBRID; MELANOMA CELL; MOLECULAR RECOGNITION; NUCLEIC ACID SYNTHESIS; STREPTOMYCES;

EID: 0344838629     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70441-3     Document Type: Article

References (21)

1. Hurley LH. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot 1977;30:349-70.
2. Kohn KW. Anthramycin. In: Corcoran JW, Hahn FE, eds. Mechanism of Action of Antimicrobial and Antitumor Agents. New York: Springer-Verlag, 1975:3-11.
3. Petrusek RL, Uhlenhopp EL, Duteau N, Hurley LH. Reaction of anthramycin with DNA. J Biol Chem 1982;257:6207-16.
4. Hurley LH, Petrusek RL. Proposed structure of the anthramycin-DNA adduct. Nature 1979;282:529-31.
5. 2 adduct. Evidence for two covalent adducts with opposite orientations and stereochemistries at the covalent linkage site. J Med Chem 1988;31: 583-90.
6. Wang JJ, Hill GC, Hurley LH. Template-directed design of a DNA-DNA cross-linker based upon a bis-tomaymycin-duplex adduct. J Med Chem 1992;35:2995-3002.
7. Mountzouris JA, Wang JJ, Thurston DE, Hurley LH. Comparison of a DSB-120 DNA interstrand cross-linked adduct with the corresponding bis-tomaymycin adduct: an example of a successful template-directed approach to drug design based upon the monoalkylating compound tomaymycin. J Med Chem 1994;37:3132-40.
8. Leimgruber W, Stefanovic V, Schenker F, et al. Isolation and characterization of anthramycin, a new antitumor antibiotic. J Am Chem Soc 1965;87:5791-3.
9. Leimgruber W, Batcho AD, Schenker F. The structure of anthramycin. J Am Chem Soc 1965;87:5793-5.
10. Arima K, Kohsaka M, Tamura G, et al. Studies on tomaymycin, a new antibiotic. Isolation and properties of tomaymycin. J Antibiot 1972;25:437-44.
11. Nishioka Y, Beppu T, Kohsaka M, Arima K. Mode of action of tomaymycin. J Antibiot 1972;25:660-7.
12. Japanese Patent JP 58, 180, 487 [83, 180, 487] (CI. CO7D487/ 04) Kyowa Hakko Kogyo Co. Ltd., Jpn Kokai Tokkyo Kono, 21 Oct 1983, Appl. 82/63, 630, 16 Apr 1982. Chem Abstr 1984; 100:173150k.
13. Hu WP, Wang JJ, Lin FL, et al. An efficient synthesis of pyrrolo [2,1-c][1,4]benzodiazepine. Synthesis of the antibiotic DC-81. J Org Chem 2001;66:2881-3.
14. Gregson SJ, Howard PW, Hartley JA, et al. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J Med Chem 2001;44:737-48.
15. Thurston DE, Bose DS. Synthesis of DNA-interactive pyrrolo [2,1-c][1,4]benzodiazepines. Chem Rev 1994;94:433-65.
16. Thurston DE, Morris SJ, Hartley JA. Synthesis of a novel GC-specific covalent-binding DNA affinity-cleavage agent based on pyrrolobenzodiazepines (PBDs). Chem Comm 1996:563-5.
17. Mahboobi S, Pongratz H, Hufsky H, et al. Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001;44:4535-53.
18. Salituro FG, Harrison BL, Baron BM, et al. 3-(2-Carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. J Med Chem 1990;33:2944-6.
19. Cross PE, Dickinson RP, Parry MJ, Randall MJ. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2-and -3-carboxylic acids. J Med Chem 1986;29:1637-43.
20. Herlyn M, Clark WH, Rodeck U, et al. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
21. Paull KD, Shoemaker RH, Boyd MR, et al. The synthesis of XTT: a new tetrazolium reagent bioreducible to a water-soluble formazan. J Heterocyclic Chem 1988;25:911-4.